Diagenode and Advanced Analytical Sign Co-Marketing Agreement
DENVILLE, NJ, and ANKENY, IA (PRWEB) October 11, 2016 -- Diagenode, Inc. and Advanced Analytical Technologies, Inc. (AATI) today announced a co-marketing agreement to promote instrument platform synergies for next-generation sequencing (NGS) library preparation. DNA shearing solutions from Diagenode coupled with Fragment Analyzer™ Automated CE Systems by AATI streamline NGS library preparation for next-generation sequencing.
Diagenode is a leading global provider of complete solutions for epigenetics and NGS sample preparation, offering instruments for precise DNA shearing: the Bioruptor® to shear DNA to fragment lengths between 150 bp and 2 kb and the Megaruptor® for fragment lengths between 3 kb and 75 kb. Diagenode’s DNA shearing devices provide high quality DNA fragments within the tight size ranges required for NGS library preparation.
AATI is an innovative analytical instrument manufacturer. The award winning Fragment Analyzer improves workflow in the laboratory by decreasing time to results and reducing overall analysis time. Due to its capabilities, the Fragment Analyzer has become the leading platform for quality control analysis of DNA and RNA in the NGS market.
“Our DNA shearing solutions enable unbiased DNA shearing for any fragment length” said Dr. Jerome Kroonen, Product Manager at Diagenode. “Combining our solutions with the Fragment Analyzer provides streamlined workflows for both short and long-read sequencing library preparation.”
“Data quality and performance requirements in the genomics industry have driven massive demand for our Fragment Analyzer systems,” added Dr. Jonathan Hagopian, Director of Business Development for Advanced Analytical. “We are excited to promote synergies with Diagenode shearing technologies.”
The companies have published an application note describing the technology pairings in the latest edition of Nature Methods:
http://www.nature.com/nmeth/journal/v13/n10/full/nmeth.f.397.html
About Diagenode:
Diagenode is a leading provider of complete solutions for epigenetic research. The company has developed a comprehensive approach to gain new insights into epigenetic studies, offering innovative shearing and automation instruments, reagent kits, high quality antibodies, and services to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company’s latest innovations include a unique, full automation system, a reduced representation bisulfite sequencing (RRBS) kit providing eight times more coverage than standard technologies, ChIP-seq kits for only 10,000 cells, and the industry’s most validated antibodies. For more information about Diagenode, please visit the company’s website at http://www.diagenode.com.
About Advanced Analytical:
Advanced Analytical Technologies, Inc., (AATI) develops, manufactures, and markets low and high-throughput, fully-automated nucleic acid analysis systems. AATI platforms optimize and accelerate complex genomics workflows for basic science and commercial applications in multiple life science industries including: genomics, molecular diagnostics, pharmaceuticals, healthcare, biotechnology, synthetic biology, biofuels, and agriculture. The company’s product portfolio has instruments for parallel analysis of DNA, RNA, and pharmaceutical compounds, using capillary electrophoresis (CE) with fluorescence or UV absorbance detection. The Fragment Analyzer™ is AATI’s flagship platform recognized as the best-in-class multi-channel automated fluorescence-based CE detection system for sizing and concentration analysis of various DNA and RNA samples including: genomic DNA, NGS libraries, CRISPR mutations, dsDNA fragments, PCR amplicons, microsatellite SSR, RFLP, total RNA, mRNA, small and microRNA, single-cell products, and cell-free isolates. Advanced Analytical has facilities in Ankeny, Iowa, USA, Paris, France and Heidelberg, Germany. More information is available at http://www.aati-us.com.
Didier Allaer, Diagenode, Inc., +1 8587747501, [email protected]
Share this article